Hüseyin Çelik, MD

Hüseyin Çelik, MD is a nephrologist in the Nephrology Department of Acibadem Health Group, which he joined in 2014. He has more than 37 years in medicine. He studied at Istanbul University Cerrahpasa Faculty of Medicine from 1983 to 1989. He then completed his Internal Medicine Residency at Istanbul Beyoglu Training and Research Hospital between 1991 and 1995, followed by a Nephrology Residency at Başkent University Faculty of Medicine between 2001 and 2005, where he completed his nephrology training in 2005.

His early professional experience included the Suşehri Tuberculosis Dispensary, Sivas (1989–1990) and the Emergency Department of Taksim First Aid Hospital (1990–1991). After his internal medicine training he worked at the Siirt State Hospital Internal Medicine Clinic from 1995 to 1998 and at the Clinic of Internal Medicine, Anamur State Hospital, İçel from 1998 to 2001. Following his nephrology residency, he practiced at the Bursa State Hospital Nephrology Clinic from 2006 to 2011. Dr. Çelik is an author of two peer-reviewed publications on peritoneal dialysis: a 2006 article in Peritoneal Dialysis International on the Malnutrition-Inflammation score as a tool in peritoneal dialysis patients, and a 2005 article in the Journal of Renal Nutrition on the influence of peritoneal transport status on atherosclerosis and inflammation in CAPD patients.

Clinical focus

Dr. Çelik’s clinical work centers on kidney disease and its long-term management. His listed areas of expertise include chronic kidney disease, acute kidney injury and renal failure. He is involved in dialysis management for patients whose kidney function has declined to the point where renal replacement therapy is being considered or is already under way.

A particular area of his experience is peritoneal dialysis, including continuous ambulatory peritoneal dialysis (CAPD). His published research addresses the assessment of malnutrition-inflammation syndrome in peritoneal dialysis patients and the relationship between peritoneal transport status, atherosclerosis and inflammation in CAPD patients. In clinical practice, the choice of dialysis modality and the management of nutritional and inflammatory status are individual decisions that depend on the patient’s overall condition, laboratory findings and personal circumstances, and are discussed with the patient after a full evaluation.

How Dr. Çelik works with international patients

Dr. Çelik speaks Turkish and English, and interpreters can be arranged for patients who speak other languages. For patients traveling from abroad, the Acibadem international patient team coordinates the collection of prior reports and imaging, arranges appointments and organises the hospital visit. A first consultation typically covers the patient’s history and symptoms, a review of existing imaging, laboratory results and previous treatments, a clinical examination and a discussion of the available options. Video consultation is available for international patients who wish to discuss their case with Dr. Çelik before deciding whether to travel.